| Efficacy and Safety of Oral Encochleated Amphotericin B for the Treatment of Cryptococcal Infection (NCT03196921) | Matinas BioPharma Nanotechnologies, Inc. | 2018-10-01 |
| A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy Subjects (NCT03657719) | Green Cross Corporation | 2018-10-01 |
| 124I-p5+14 Injection Safety in Subjects With Systemic Amyloidosis (NCT03678259) | University of Tennessee Graduate School of Medicine | 2018-10-01 |
| Norepinephrine or Phenylephrine in Bolus for Hypotension in Cesarean Delivery (NCT03702400) | Hospital dos Servidores do Estado do Rio de Janeiro | 2018-10-01 |
| Evaluation of 2 Intensification Treatment Strategies for Neuroblastoma Patients With a Poor Response to Induction (NCT03165292) | Gustave Roussy, Cancer Campus, Grand Paris | 2018-10-01 |
| Bacteriotherapy to Improve Underarm Odor (NCT03967470) | University Ghent | 2018-10-01 |
| Hypofractionated Radiotherapy With Carboplatin and Paclitaxel in Non-Small Cell Lung Cancer (NCT03699033) | Stephanie Smiddy | 2018-10-01 |
| SAbR For Oligo-Progressive Renal Cell Cancer. (NCT03696277) | University of Texas Southwestern Medical Center | 2018-10-01 |
| Translational Study of Nivolumab in Combination With Bevacizumab for Recurrent Glioblastoma (NCT03890952) | Ulrik Lassen | 2018-10-01 |
| Prevention of Dry Socket by Means of Single Preoperative Antibiotics Compared to Conventional Therapy (NCT03992144) | Dow University of Health Sciences | 2018-10-01 |
| Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes (NCT03620773) | University of Colorado, Denver | 2018-10-01 |
| High Dose Omega 3 in People at Risk for Dementia (NCT03926351) | University Hospital, Akershus | 2018-10-01 |
| IPACK Block in Total Knee Arthroplasty (NCT03692858) | Asklepieion Voulas General Hospital | 2018-10-01 |
| Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients (NCT03613727) | Virginia Commonwealth University | 2018-10-01 |
| Peer Support Intervention to Mitigate Social Isolation and Stigma of Adolescent Motherhood in Zimbabwe (NCT05213182) | West Chester University of Pennsylvania | 2018-10-01 |
| Peanuts and Glycemic Control (NCT03654651) | Penn State University | 2018-10-01 |
| Ibudilast for the Treatment of Alcohol Use Disorder (NCT03594435) | University of California, Los Angeles | 2018-10-01 |
| Immunotherapy +/- EGFR Inhibitor In Advanced/Metastatic cSCC: Tackling Primary And Secondary Resistance (NCT03666325) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2018-10-01 |
| Montage-Enhanced Sternal Closure (NCT03365843) | University of Calgary | 2018-10-01 |
| BFPET for Regional Myocardial Perfusion Imaging (NCT02252783) | Fluoropharma, Inc. | 2018-10-01 |
| The Safety/Efficacy of hUC Mesenchymal Stem Cells（19#iSCLife®-OA） Therapy for Patients With Osteoarthritis (NCT03383081) | Sclnow Biotechnology Co., Ltd. | 2018-10-01 |
| A Study to Evaluate Safety, Tolerability, and Efficacy Profile of Rivoceranib With Paclitaxel in Advanced Gastric or Gastroesophageal Junction Cancer (NCT03707028) | Elevar Therapeutics | 2018-10-01 |
| Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding (NCT04499898) | Sherief Abd-Elsalam | 2018-10-01 |
| Safety and Efficacy of Hydrochlorothiazide in the Treatment of Hypernatremia in Critically Ill Patients (NCT03658850) | University of Sao Paulo | 2018-10-01 |
| Rh-Endostatin (Endostar®) Continuous Intravenous Infusion (NCT03706703) | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | 2018-10-01 |
| Clinical Study of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for Treatment of Knee Osteoarthritis (NCT03166865) | Liaocheng People's Hospital | 2018-10-01 |
| The Safety and Efficiency Study of Mesenchymal Stem Cell (19#iSCLife®-POI) in Premature Ovarian Insufficiency (NCT03816852) | Sclnow Biotechnology Co., Ltd. | 2018-10-01 |
| A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic Syndrome (NCT03703908) | Amgen | 2018-10-01 |
| A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System (NCT03648372) | Takeda | 2018-10-01 |
| Atezolizumab in Combination With Bevacizumab, Carboplatin and Pemetrexed for EGFR-mutant Metastatic NSCLC Patients After Failure of EGFR Tyrosine Kinase Inhibitors (NCT03647956) | The University of Hong Kong | 2018-10-01 |
| Icotinib as Neoadjuvant and Adjuvant Therapy in EGFR-mutant Stage IIIB or Oligometastasis Non-small Cell Lung Cancer (NCT03349203) | Betta Pharmaceuticals Co., Ltd. | 2018-10-01 |
| A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors (NCT03693014) | Memorial Sloan Kettering Cancer Center | 2018-10-01 |
| Treatment of Tendon Disease Using Autologous Adipose-derived Mesenchymal Stem Cells (NCT03279796) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2018-10-01 |
| Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer (NCT03175341) | Academic Emergency County Hospital Sibiu | 2018-10-01 |
| Secretin for Acute Pancreatitis (NCT03686618) | ChiRhoClin, Inc. | 2018-10-01 |
| HMA+DLI vs DLI Preemptive Therapy Based on MRD for AL Undergoing Allo-HSCT (NCT03662087) | Nanfang Hospital, Southern Medical University | 2018-10-01 |
| Capecitabine in HER-2 Positive Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy (NCT03684863) | Shandong Cancer Hospital and Institute | 2018-10-01 |
| A Clinical Method Development Study to Characterise The Efficacy of a Dentifrice For The Relief Of Dentin Hypersensitivity (NCT03361774) | GlaxoSmithKline | 2018-10-01 |
| Alternate Day Dosing of Pomalidomide in Patients With Refractory Multiple Myeloma (NCT03520985) | Swiss Cancer Institute | 2018-10-01 |
| G56W1 in Women With Postmenopausal Osteoporosis (NCT03720886) | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 2018-10-01 |
| Nivolumab in Platinum Recurrent or Refractory Metastatic Germ Cell Tumors (NCT03726281) | Hospital Beatriz Ângelo | 2018-10-01 |
| Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study (NCT03584217) | University of Colorado, Denver | 2018-10-01 |
| A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495/KEYNOTE-495) (NCT03516981) | Merck Sharp & Dohme LLC | 2018-10-01 |
| Epacadostat in Combination With Pembrolizumab and Azacitidine in Subjects With Metastatic Colorectal Cancer (NCT03182894) | James J Lee | 2018-09-30 |
| Recombinant Human Anti-PD-1 Monoclonal Antibody HX008 Injection for the Treatment of Advanced Solid Tumors (NCT03704246) | Taizhou Hanzhong biomedical co. LTD | 2018-09-30 |
| Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (NCT03654755) | Asana BioSciences | 2018-09-29 |
| A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations (NCT03703570) | Kyowa Kirin Co., Ltd. | 2018-09-29 |
| Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions (NCT02432066) | University of Florida | 2018-09-29 |
| CAR T and PD-1 Knockout Engineered T Cells for Esophageal Cancer (NCT03706326) | The First Affiliated Hospital of Guangdong Pharmaceutical University | 2018-09-28 |
| Aflibercept and 5-FU vs. FOLFOX as 1st Line Treatment for Elderly or Frail Elderly Patients With Met. Colorectal Cancer (NCT03530267) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2018-09-28 |
| Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma (NCT03661723) | Dana-Farber Cancer Institute | 2018-09-28 |
| Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study (NCT03682965) | Christopher Thompson, MD | 2018-09-28 |
| QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine (NCT03563157) | ImmunityBio, Inc. | 2018-09-28 |
| Efficacy Evaluation of Focused HIFU (High Intensity Focused Ultrasound) Therapy in Patients With Localized Intermediate Risk Prostate Cancer (NCT03568188) | Hospices Civils de Lyon | 2018-09-28 |
| A Study to Evaluate the Long-term Safety and Efficacy of Fenebrutinib in Participants Previously Enrolled in a Fenebrutinib Chronic Spontaneous Urticaria (CSU) Study (NCT03693625) | Genentech, Inc. | 2018-09-27 |
| A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003) (NCT03634540) | Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2018-09-27 |
| The Effect of Nicotinamide Riboside on Skeletal Muscle Function in Heart Failure Subjects (NCT03565328) | National Heart, Lung, and Blood Institute (NHLBI) | 2018-09-27 |
| Effect of Different Weight Vests on Body Weight in Obese Individuals (NCT03672903) | Vastra Gotaland Region | 2018-09-27 |
| Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix (NCT03610581) | Janssen Vaccines & Prevention B.V. | 2018-09-27 |
| A Clinical Study to Test How Effective and Safe GLPG1205 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) (NCT03725852) | Lakefront Biotherapeutics NV | 2018-09-27 |
| A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM (NCT03723655) | Bristol-Myers Squibb | 2018-09-27 |
| Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone (NCT03660826) | National Cancer Institute (NCI) | 2018-09-27 |
| Exemestane in Post-Menopausal Women With NSCLC (NCT02666105) | Masonic Cancer Center, University of Minnesota | 2018-09-27 |
| CAMPSIITE™ RGX-121 Gene Therapy in Subjects With MPS II (Hunter Syndrome) (NCT03566043) | REGENXBIO Inc. | 2018-09-27 |
| A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Colorectal Cancer (Morpheus-CRC) (NCT03555149) | Hoffmann-La Roche | 2018-09-27 |
| Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence (NCT03219372) | Cedars-Sinai Medical Center | 2018-09-27 |
| Photobiomodulation for Breast Cancer Radiodermatitis (NCT04059809) | AC Camargo Cancer Center | 2018-09-26 |
| Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer (NCT03579771) | Emory University | 2018-09-26 |
| Topical Antibiotics in Chronic Rhinosinusitis (NCT03673956) | Mayo Clinic | 2018-09-26 |
| A Study to Evaluate the Effect of MEDI0382 on Energy Balance in Overweight and Obese Participants With Type 2 Diabetes Mellitus (NCT03596177) | MedImmune LLC | 2018-09-26 |
| A Study to Evaluate the Efficacy and Safety of Bedaquiline (TMC207) in Participants With Multibacillary Leprosy (NCT03384641) | Janssen Research & Development, LLC | 2018-09-26 |
| Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL) (NCT03547700) | University of Michigan Rogel Cancer Center | 2018-09-26 |
| Auto Fecal Microbial Transplant Post Helicobacter Pylori Antibiotic Therapy (NCT05329636) | Tel-Aviv Sourasky Medical Center | 2018-09-26 |
| Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa (NCT03326336) | GenSight Biologics | 2018-09-26 |
| A Study of RC48-ADC in Subjects With Advanced Non-small Cell Lung Cancer (NCT04311034) | RemeGen Co., Ltd. | 2018-09-26 |
| Study of Osimertinib and Stereotactic Ablative Radiation (SABR) in EGFR Mutant NSCLC (NCT03667820) | University of Texas Southwestern Medical Center | 2018-09-26 |
| Metformin Therapy in Non-diabetic AAA Patients (NCT03507413) | Medical University of Vienna | 2018-09-26 |
| A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma (NCT03671018) | Hoffmann-La Roche | 2018-09-25 |
| Conjugate Vaccine Against Meningococcus C a Brazilian Project (NCT02858570) | The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | 2018-09-25 |
| Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant (NCT03589040) | Makerere University | 2018-09-25 |
| Poly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1 (NCT03721679) | Oncovir, Inc. | 2018-09-25 |
| Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001 (NCT02655601) | BioMimetix JV, LLC | 2018-09-25 |
| Efficacy of OC-01 Nasal Spray on Goblet Cell and Meibomian Gland Stimulation (NCT03688802) | Oyster Point Pharma, Inc. | 2018-09-25 |
| Carbohydrate Restricted Diet Intervention for Men on Prostate Cancer Active Surveillance (NCT03679260) | Cedars-Sinai Medical Center | 2018-09-25 |
| Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab (NCT03674567) | RAPT Therapeutics, Inc. | 2018-09-25 |
| PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study (NCT03686332) | The Netherlands Cancer Institute | 2018-09-25 |
| Use of Venetoclax as Single Agent in Patients With Relapsed/Refractory BCL-2 Positive Peripheral T Cell Lymphoma (NCT03552692) | Fondazione Italiana Linfomi - ETS | 2018-09-25 |
| MB-CART20.1 Lymphoma (NCT03664635) | Miltenyi Biomedicine GmbH | 2018-09-25 |
| rVA576 in Adult Mild to Moderate Bullous Pemphigoid Subjects (NCT04035733) | AKARI Therapeutics | 2018-09-25 |
| Phase 1/2a Clinical Trial to Assess the Safety of HB-adMSCs for the Treatment of Rheumatoid Arthritis (NCT03691909) | Hope Biosciences LLC | 2018-09-25 |
| A Study of PRCL-02 in Moderate to Severe Chronic Plaque Psoriasis (NCT03614078) | PRCL Research Inc. | 2018-09-25 |
| [18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors (NCT03276676) | University of Utah | 2018-09-24 |
| Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults (NCT03658629) | Novavax | 2018-09-24 |
| Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia (NCT03289910) | National Cancer Institute (NCI) | 2018-09-24 |
| Role of Topical Treatments in the Modulation of Skin Microbiome in Psoriatic Skin (NCT03584360) | Centre Hospitalier Universitaire de Nice | 2018-09-24 |
| The TARGET BP OFF-MED Trial (NCT03503773) | Ablative Solutions, Inc. | 2018-09-24 |
| Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer (NCT03624660) | University of Florida | 2018-09-24 |
| An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis (NCT03573505) | Biogen | 2018-09-24 |
| A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata (NCT03570749) | Eli Lilly and Company | 2018-09-24 |
| PARCT: Trial of Atezolizumab in Relapsed/Refractory Cutaneous T Cell Lymphoma (CTCL) (NCT03357224) | European Organisation for Research and Treatment of Cancer - EORTC | 2018-09-24 |